Hemostats Market

Date: 2016-05

Hemostats are instruments used to reduce or halt bleeding during surgery. These can be enabled by the time privileged approaches of smearing pressure, stitching the bleeding or using thermal energy devices. Hemostats generally are used to make the blood clot. Topical hemostatic agents are used in an extensive variety of surgical situations, and the development is a technical advancement in the history of medicine.

Hemostasis, which is a complex process of activating platelets and plasma clotting, can be divided into two distinct processes, primary and secondary hemostasis. Primary hemostasis results in the development of soft platelet plugs, which eventually are steadied and cross-linked through secondary hemostasis. The activation of the clotting cascade is of dominant prominence in both primary and secondary hemostasis. The hemostats market can be divided into by type, treatment and end user segment. Hemostats by product type can be further segmented into thrombin based, collagen based, gelatin based, combination based, oxidized cellulose based and others. These hemostats fin their applications into variety of surgical treatments like cardio therapeutics, spine surgery, pulmonary surgery and many others. The key end users include hospitals, surgery centers, nursing homes and others

The global market for hemostats is estimated to be $XX billion in 2015. The global market for hemostats market is forecast to grow at a CAGR of XX% to reach $XX billion by 2021. The main uses of hemostats in everyday surgical practice are neurosurgery like skull and brain injuries, spine and spinal cord surgery, endoscopic surgery and so on. Nowadays, surgery of aneurisms only needs hemostatic agents in the process to shield the brain and halt the indistinct bleedings.

Geographically, the hemostats market has been segmented into four major regions which include Americas, Europe, Asia-Pacific and Rest of the World. Among the four regions Americas was the leading market in 2015 and is estimated to continue with the growing trend. The report delivers an in-depth study on possible prospects of disparate end-users as well as numerous types of hemostats and key markets in each region. The market for hemostats is swiftly growing with technological advancements and cumulative number of surgeries. Also, hospitals and healthcare facilities are gradually growing, maintained by government which in turn is driving the growth of hemostats market.

Some of the major companies dealing with the manufacturing of hemostats include:

Johnson & Johnson Services, Inc. (U.S.)
Pfizer Inc. (U.S.)
Equimedical (Netherlands)
C. R. Bard, Inc. (U.S.)
B Braun Melsungen AG (Germany)
Vascular Solutions, Inc. (U.S.)
Gelita Medical GmbH (Germany)
Integra Lifesciences Holdings Corporation (U.S.)
Baxter (U.S.) to name among a few others

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample